7 Einträge gefunden

1. Efficacy and Safety of Ixekizumab Versus Adalimumab in Biologic-naïve Patients With Active Psoriatic Arthritis and Moderate-to-severe Psoriasis: 52-week Results From the Randomized SPIRIT-H2H Trial

   1. Reich, Kristian
   2. Kristensen, Lars Erik
   3. Smith, Saxon D
   4. Rich, Phoebe
   5. Sapin, Christophe
   6. Leage, Soyi Liu
   7. McKenzie, Robert

   2022 - Forschungsinformationssystem des UKE - frei zugänglich
2. Early Response is Associated With Stable Long-Term Response in Psoriasis Patients Receiving Ixekizumab or Ustekinumab

   1. Augustin, Mathias
   2. Gallo, Gaia
   3. See, Kyoungah
   4. McKean-Matthews, Missy
   5. Burge, Russel
   6. Gooderham, Melinda
   7. Reich, Kristian

   2022 - Forschungsinformationssystem des UKE
3. Bimekizumab versus Secukinumab in Plaque Psoriasis

   1. Reich, Kristian
   2. Warren, Richard B
   3. Lebwohl, Mark
   4. Gooderham, Melinda
   5. Strober, Bruce
   6. Langley, Richard G
   7. Paul, Carle

   2021 - Forschungsinformationssystem des UKE - frei zugänglich
4. Safety of Ixekizumab Treatment for up to 5 Years in Adult Patients with Moderate-to-Severe Psoriasis: Results from Greater Than 17,000 Patient-Years of Exposure

   1. Armstrong, April
   2. Paul, Carle
   3. Puig, Luis
   4. Boehncke, Wolf Henning
   5. Freeman, Michael
   6. Torii, Hideshi
   7. Papp, Kim

   2020 - Forschungsinformationssystem des UKE
5. Efficacy and Safety of Ixekizumab Through 5 Years in Moderate-to-Severe Psoriasis: Long-Term Results from the UNCOVER-1 and UNCOVER-2 Phase-3 Randomized Controlled Trials

   1. Leonardi, Craig
   2. Reich, Kristian
   3. Foley, Peter
   4. Torii, Hideshi
   5. Gerdes, Sascha
   6. Guenther, Lyn
   7. Gooderham, Melinda

   2020 - Forschungsinformationssystem des UKE
6. Risankizumab compared with adalimumab in patients with moderate-to-severe plaque psoriasis (IMMvent): a randomised, double-blind, active-comparator-controlled phase 3 trial

   1. Reich, Kristian
   2. Gooderham, Melinda
   3. Thaçi, Diamant
   4. Crowley, Jeffrey J
   5. Ryan, Caitriona
   6. Krueger, James G
   7. Tsai, Tsen-Fang

   2019 - Forschungsinformationssystem des UKE
7. Tofacitinib Improves Pruritus and Health-Related Quality of Life up to 52 weeks: Results from 2 Randomized Phase III Trials in Patients With Moderate to Severe Plaque Psoriasis

   1. Feldman, Steven R
   2. Thaçi, Diamant
   3. Gooderham, Melinda
   4. Augustin, Matthias
   5. de la Cruz, Claudia
   6. Mallbris, Lotus
   7. Buonanno, Marjorie

   2016 - Forschungsinformationssystem des UKE